ALISERTIB SODIUM ANHYDROUS
UNII 23KN826MQ4

Substance Identification & Data

This profile provides standardized clinical and technical data for Alisertib Sodium Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 23KN826MQ4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1028486-06-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

23KN826MQ4

CAS Registry Number

1028486-06-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ALISERTIB SODIUM ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C27H19ClFN4O4.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

AIUYVPGHBMKGAC-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C216268

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

66819785

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(c1c(cc(cc1)Nc2nc-3c(CN=C(c4c3ccc(c4)Cl)c5c(cccc5OC)F)cn2)OC)(=O)[O-].[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Alisertib Sodium Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.